Neumora Therapeutics, Inc. (NMRA)
(Delayed Data from NSDQ)
$11.79 USD
-0.20 (-1.67%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $11.82 +0.03 (0.25%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.39 | 2.56% |
Earnings Summary
For their last quarter, Neumora Therapeutics, Inc. (NMRA) reported earnings of -$0.37 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for NMRA's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.39 per share, reflecting a year-over-year increase of 65.79%.
Earnings History
Price & Consensus
Zacks News for NMRA
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
NMRA: What are Zacks experts saying now?
Zacks Private Portfolio Services